Home » Clinical Trials » Therapeutic Areas
Therapeutic Areas: Cardiology/Vascular Diseases | Psychiatry/Psychology | Pulmonary/Respiratory Diseases
Disease Category: Smoking Cessation
Location: United States, TN
Smoking Cessation Study
We are currently recruiting smokers who are really motivated to quit smoking. The purpose of the study is to evaluate the safety and effectiveness of three approved medications, Habitrol, Zyban and Chantix, in combination and compared to a placebo (no active ingredient). Requires 12 weekly visits.
Patient Inclusion Criteria:
Patient Exclusion Criteria:
CW ID: 182300
Date Last Changed:
July 18, 2013
Melissa Carro, Director of MarketingClinical Research Associates, Inc.1500 Church StreetNashville, TN 37203Phone: 615-329-2222 ext. 304
Clinical Research Associates, Inc.
If you would like to learn more about participating in this research study, please email the trial contact using the form below.
We value your privacy and your information will only be used by the research center to contact
you regarding this study.
DISCLAIMER: CenterWatch does not conduct clinical research.
CenterWatch is a publishing company that posts clinical trials information on behalf of sponsor companies,
contract research organizations, clinical research sites and other interested parties. This information
is designed to help patients find clinical trials of interest and contact the research centers
conducting the trials.
Copyright © 1995-2017 CenterWatch.